Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07042126 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of 611 in Chinese Adolescents With Moderate to Severe Atopic Dermatitis

Name: Evaluation of 611 in Chinese Adolescents With Moderate to Severe Atopic Dermatitis — clinical trial record (NCT07042126)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 3

SponsorSunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Started2025-08-05

View on ClinicalTrials.gov ↗

Record status

This record was last updated November 18, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.

Amendment history

2025-11-16

Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1

Trial statusNot Yet Recruiting→Recruiting

Start dateestimated 2025-06-16→confirmed 2025-08-05

Study sitesdetails revised at 3 of 3 sites

2025-06-19

Original filing

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

22 trials monitored

See all monitored trials

Atopic Dermatitis

489 trials monitored

See 14 trials at risk

The primary objective of the study was to evaluate the efficacy of 611 in Chinese Adolescents with moderate to severe atopic dermatitis.

Trial Details

NCT Number	NCT07042126
Lead Sponsor	Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Conditions	Dermatitis, Atopic
Enrollment	180 participants
Start Date	2025-08-05
Primary Completion	2026-06-30 (estimated)
Study Completion	2027-09-30 (estimated)
Updated on ClinicalTrials.gov	2025-11-18